Clinical Trials
33 trialsStudying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Study of Bone Marrow Samples From Patients With Acute Leukemia
Eastern Cooperative Oncology Group
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
Eastern Cooperative Oncology Group
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
Children's Oncology Group
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial
Children's Oncology Group
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
Children's Oncology Group
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia
Children's Oncology Group
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
Children's Oncology Group
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
SWOG Cancer Research Network
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin
SWOG Cancer Research Network
S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
SWOG Cancer Research Network
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
National Cancer Institute (NCI)
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
National Cancer Institute (NCI)